DK1675625T3 - Mekanisme-baseret målrettet pancreatisk beta-celle-afbildning - Google Patents

Mekanisme-baseret målrettet pancreatisk beta-celle-afbildning

Info

Publication number: DK1675625T3
Authority: DK; Denmark
Prior art keywords: pancreatic beta; cell imaging; based targeted; targeted pancreatic; imaging
Prior art date: 2003-09-17

Application number

DK04788800.3T

Other languages

English (en)

Inventor

David J Yang

Saady Kohanim

Dong-Fang Yu

Ali Azhdarinia

Jerry Bryant

Chang-Sok Oh

Original Assignee

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-17

Filing date

2004-09-16

Publication date

2013-05-13

2004-09-16 Application filed by Univ Texas filed Critical Univ Texas

2013-05-13 Application granted granted Critical

2013-05-13 Publication of DK1675625T3 publication Critical patent/DK1675625T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Optics & Photonics (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK04788800.3T 2003-09-17 2004-09-16 Mekanisme-baseret målrettet pancreatisk beta-celle-afbildning DK1675625T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US50368303P	2003-09-17	2003-09-17
PCT/US2004/030374 WO2005027981A1 (en)	2003-09-17	2004-09-16	Mechanism-based targeted pancreatic beta cell imaging and therapy

Publications (1)

Publication Number	Publication Date
DK1675625T3 true DK1675625T3 (da)	2013-05-13

Family

ID=34375381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04788800.3T DK1675625T3 (da)	2003-09-17	2004-09-16	Mekanisme-baseret målrettet pancreatisk beta-celle-afbildning

Country Status (16)

Country	Link
US (2)	US7611693B2 (da)
EP (2)	EP1675625B1 (da)
JP (3)	JP5395327B2 (da)
KR (2)	KR20110119813A (da)
CN (1)	CN1867363B (da)
AU (1)	AU2004273911B2 (da)
BR (1)	BRPI0414512B8 (da)
CA (1)	CA2539384C (da)
DK (1)	DK1675625T3 (da)
ES (1)	ES2403378T3 (da)
HK (1)	HK1094312A1 (da)
IL (1)	IL174374A (da)
NO (1)	NO336658B1 (da)
PL (1)	PL1675625T3 (da)
PT (1)	PT1675625E (da)
WO (1)	WO2005027981A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7611693B2 (en) *	2003-09-17	2009-11-03	Board Of Regents, The Univerisity Of Texas System	Mechanism-based targeted pancreatic beta cell imaging and therapy
WO2006104401A1 (en) *	2005-03-26	2006-10-05	Protemix Corporation Limited	Copper antagonist compositions
AU2006266229B2 (en) *	2005-06-29	2013-02-21	The Trustees Of Columbia University In The City Of New York	Use of DTBZ for imaging endocrine pancreas and beta cell mass in type 1 diabetes
WO2008038302A2 (en) *	2006-09-26	2008-04-03	Jegannathan Srinivas	Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger.
WO2008038304A2 (en) *	2006-09-26	2008-04-03	Jegannathan Srinivas	Therapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger.
CA2719623A1 (en)	2008-03-24	2009-10-01	The Board Of Regents Of The University Of Texas System	Image-guided therapy of myocardial disease: composition, manufacturing and applications
EP2460542A4 (en) *	2009-07-31	2015-02-18	Riken	ENDOKRINER PANCREAS CELL INDICATOR AND ITS USE

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2951135A1 (de)	1979-12-19	1981-06-25	Hoechst Ag, 6230 Frankfurt	Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
JPS57102820A (en)	1980-12-19	1982-06-26	Nippon Mejifuijitsukusu Kk	Agent for radiodiagnosis
JPS5944329A (ja)	1982-09-07	1984-03-12	Nippon Mejifuijitsukusu Kk	新規な放射性診断剤
JPS59193833A (ja)	1983-04-19	1984-11-02	Nippon Mejifuijitsukusu Kk	新規な二官能配位子化合物含有放射性診断剤
US4732864A (en)	1983-10-06	1988-03-22	E. I. Du Pont De Nemours And Company	Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS6354321A (ja)	1985-03-27	1988-03-08	Ajinomoto Co Inc	血糖降下剤
JPH01186899A (ja) *	1988-01-18	1989-07-26	Nippon Mejifuijitsukusu Kk	膜透過性を有するＴｃ−９９ｍ単核錯体
MY106120A (en) *	1988-12-05	1995-03-31	Novartis Ag	Peptide derivatives.
US5094837A (en)	1990-01-22	1992-03-10	Wayne State University	Method for use of magnetic resonance imaging to image pancreas using secretin
US4994258A (en)	1990-03-05	1991-02-19	Merck & Co., Inc.	Gamma emitting, CCK-A antagonists for pancreatic imaging
FR2661187B1 (fr)	1990-04-20	1994-08-05	Inst Nat Sante Rech Med	Proteine associee a la pancreatite aiguue. moyens pour le diagnostic de la pancreatite aiguue.
JPH05186372A (ja)	1991-07-18	1993-07-27	Green Cross Corp:The	脂肪乳剤及びｍｒｉ診断用造影剤
US5463116A (en)	1991-07-30	1995-10-31	Ajinomoto Co., Inc.	Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
JP3465247B2 (ja)	1992-12-28	2003-11-10	アベンティスファーマ株式会社	動脈硬化症の予防および治療剤
US5656600A (en) *	1993-03-25	1997-08-12	Corvas International, Inc.	α-ketoamide derivatives as inhibitors of thrombosis
US5879657A (en) *	1993-03-30	1999-03-09	The Dupont Merck Pharmaceutical Company	Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DE4336159A1 (de)	1993-10-22	1995-04-27	Kurt Heinz Prof Dr Bauer	Hochwirksame, den Wirkstoff schnell oder kontrolliert freisetzende Zubereitungsformen von Sulfonylharnstoffen und Verfahren zu deren Herstellung
US5763200A (en) *	1995-05-12	1998-06-09	Biomeasure, Incorporated	Inhibition of amylin release
WO1998033531A1 (en) *	1997-02-03	1998-08-06	Mallinckrodt Medical, Inc.	Method for the detection and localization of malignant human tumours
WO2000023603A2 (en)	1998-10-21	2000-04-27	Arch Development Corporation	Methods of treatment of type 2 diabetes
US6358491B1 (en) *	1999-08-27	2002-03-19	Berlex Laboratories, Inc.	Somatostatin analogs
JP4822039B2 (ja) *	1999-12-28	2011-11-24	味の素株式会社	経口投与用糖尿病薬製剤
SK14922002A3 (sk) *	2000-03-17	2003-04-01	Ajinomoto Co., Inc.	Farmaceutický prostriedok na prevenciu, zlepšenie a/alebo liečenie diabetickej komplikácie a použitie postprandiálnej látky na zníženie hladiny krvného cukru
AU2001285145A1 (en)	2000-08-21	2002-03-04	Millennium Pharmaceuticals, Inc.	Human abc transporter family member and uses thereof
AU2002338572A1 (en)	2001-04-13	2002-11-11	Millennium Pharmaceuticals, Inc.	66784, a novel human potassium channel and uses therefor
US7611693B2 (en) *	2003-09-17	2009-11-03	Board Of Regents, The Univerisity Of Texas System	Mechanism-based targeted pancreatic beta cell imaging and therapy

2004
- 2004-09-16 US US10/942,615 patent/US7611693B2/en active Active
- 2004-09-16 PT PT47888003T patent/PT1675625E/pt unknown
- 2004-09-16 JP JP2006527025A patent/JP5395327B2/ja active Active
- 2004-09-16 PL PL04788800T patent/PL1675625T3/pl unknown
- 2004-09-16 DK DK04788800.3T patent/DK1675625T3/da active
- 2004-09-16 EP EP04788800A patent/EP1675625B1/en active Active
- 2004-09-16 AU AU2004273911A patent/AU2004273911B2/en active Active
- 2004-09-16 CA CA2539384A patent/CA2539384C/en active Active
- 2004-09-16 ES ES04788800T patent/ES2403378T3/es active Active
- 2004-09-16 KR KR1020117021985A patent/KR20110119813A/ko not_active Application Discontinuation
- 2004-09-16 KR KR1020067005445A patent/KR101152729B1/ko active IP Right Grant
- 2004-09-16 CN CN2004800300890A patent/CN1867363B/zh active Active
- 2004-09-16 EP EP11188976A patent/EP2474328A3/en not_active Withdrawn
- 2004-09-16 WO PCT/US2004/030374 patent/WO2005027981A1/en active Application Filing
- 2004-09-16 BR BRPI0414512A patent/BRPI0414512B8/pt active IP Right Grant
2006
- 2006-03-16 IL IL174374A patent/IL174374A/en active IP Right Grant
- 2006-04-11 NO NO20061645A patent/NO336658B1/no unknown
- 2006-12-15 HK HK06113846.3A patent/HK1094312A1/xx unknown
2009
- 2009-11-02 US US12/610,857 patent/US20100278731A1/en not_active Abandoned
2010
- 2010-12-03 JP JP2010270880A patent/JP2011052016A/ja active Pending
2014
- 2014-12-17 JP JP2014254707A patent/JP2015078223A/ja active Pending

Also Published As

Publication number	Publication date
KR20110119813A (ko)	2011-11-02
CN1867363B (zh)	2010-05-12
EP2474328A2 (en)	2012-07-11
US20100278731A1 (en)	2010-11-04
KR20060104984A (ko)	2006-10-09
NO336658B1 (no)	2015-10-12
US20050100506A1 (en)	2005-05-12
AU2004273911A1 (en)	2005-03-31
JP2015078223A (ja)	2015-04-23
PT1675625E (pt)	2013-05-23
AU2004273911B2 (en)	2010-04-15
PL1675625T3 (pl)	2013-08-30
EP1675625A4 (en)	2009-07-15
NO20061645L (no)	2006-04-11
EP1675625A1 (en)	2006-07-05
KR101152729B1 (ko)	2012-06-15
US7611693B2 (en)	2009-11-03
WO2005027981A1 (en)	2005-03-31
BRPI0414512B8 (pt)	2021-05-25
JP2007505915A (ja)	2007-03-15
CN1867363A (zh)	2006-11-22
JP5395327B2 (ja)	2014-01-22
EP1675625B1 (en)	2013-02-20
HK1094312A1 (en)	2007-03-30
BRPI0414512A (pt)	2006-11-07
CA2539384A1 (en)	2005-03-31
ES2403378T3 (es)	2013-05-17
JP2011052016A (ja)	2011-03-17
EP2474328A3 (en)	2012-07-18
CA2539384C (en)	2012-08-28
IL174374A0 (en)	2006-08-01
IL174374A (en)	2011-12-29
BRPI0414512B1 (pt)	2020-11-17

Publication	Publication Date	Title
DE602005026825D1 (de)	2011-04-21	Endoskop
DE602004026245D1 (de)	2010-05-12	Endoskop
DE602004021746D1 (de)	2009-08-13	Endoskop
DE602004021940D1 (de)	2009-08-20	Endoskopsystem
FR2874814B1 (fr)	2007-11-16	Cage intervertebrale
DE602005027052D1 (de)	2011-05-05	Endoskopbehandlungssystem
DK1654360T3 (da)	2008-02-25	Amplificering fremgangsmåde
ITMI20041123A1 (it)	2004-09-03	Fissaggio
NO20062387L (no)	2006-05-31	Novel imaging agents
DE602006004919D1 (de)	2009-03-12	Endoskopsystem
DE602005027499D1 (de)	2011-05-26	Endoskopsystem
DE602005026950D1 (de)	2011-04-28	Tomographiesystem
DE602006019183D1 (de)	2011-02-10	Elektronisches Endoskopsystem
DE602005026124D1 (de)	2011-03-10	Endoskop
DE602004017313D1 (de)	2008-12-04	Endoskopische befestigungsvorrichtung
DE502005008468D1 (de)	2009-12-24	Bildaufnahmesystem
FI20041008A0 (fi)	2004-07-22	Langaton intraoraalikuvantaminen
FR2863472B1 (fr)	2006-12-29	Endoscope
DE602005012474D1 (de)	2009-03-12	Bilderzeugung
DK1675625T3 (da)	2013-05-13	Mekanisme-baseret målrettet pancreatisk beta-celle-afbildning
NO20035094D0 (no)	2003-11-14	Avbildingssystem
DE502005005082D1 (de)	2008-10-02	Bildaufnahmesystem
FR2877833B1 (fr)	2007-10-12	Correcteur de lordoses
DE602004031792D1 (de)	2011-04-21	Bilderzeugungssystem
FR2869737B1 (fr)	2007-03-30	Boitier de motoreducteur